Alere shares fall after it sued Abbott over $5.8 billion deal

Alere fell 3 percent Friday after it sued Abbott Laboratories to compel it to get all antitrust approvals required to complete its $5.8 billion merger deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.